Colgate-Palmolive Co. 2006 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2006. Colgate-Palmolive is a leading global consumer products company operating in over 200 countries. The business is organized into two primary segments: Oral, Personal and Home Care and Pet Nutrition (Hill's). In 2006, the company executed a strategy to prioritize higher-margin businesses, acquiring Tom's of Maine to enter the health and specialty trade channel and divesting its Latin American and Canadian bleach brands.
Key Financial Metrics
| Metric | 2006 | 2005 |
|---|---|---|
| Net Sales | $12,237.7 million | $11,396.9 million |
| Gross Profit Margin | 54.8% | 54.4% |
| Operating Profit | $2,160.5 million | $2,215.0 million |
| Net Income | $1,353.4 million | $1,351.4 million |
| Diluted EPS | $2.46 | $2.43 |
| Operating Cash Flow | $1,821.5 million | $1,784.4 million |
| Total Debt | $3,671.2 million | $3,446.2 million |
| Capital Expenditures | $476.4 million | $389.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Worldwide sales increased 7.5% to $12.24 billion, driven by unit volume gains of 5.5%, net selling price increases of 1.5%, and a positive foreign exchange impact of 0.5%.
- Profitability: Operating profit decreased 2% to $2.16 billion. This decline was primarily due to increased restructuring charges ($212.6 million), lower gains on the sale of non-core brands, and incremental stock-based compensation expenses ($69.8 million) resulting from the adoption of SFAS 123R.
- Segment Performance:
- Latin America: Sales surged 15.0% and operating profit rose 25%.
- Pet Nutrition: Sales grew 10.0% and operating profit increased 9%.
- North America: Sales grew 3.0% and operating profit increased 1%.
- Restructuring: The company incurred $395.4 million in pretax charges related to the 2004 Restructuring Program, compared to $182.8 million in 2005. This program aims to rationalize manufacturing facilities and reduce the workforce by approximately 12%.
Guidance, Outlook, and Risks
Outlook: Management expects market conditions to remain highly competitive in 2007 but believes the company is well-positioned for continued growth. Capital expenditures for 2007 are expected to increase to approximately 5% of net sales. The company intends to continue paying increasing annual dividends.
Risks and Contingencies:
- Legal Proceedings: Significant ongoing disputes exist in Brazil regarding the 1995 Kolynos acquisition, involving potential fines and tax assessments totaling approximately $220 million. The company recently won an appeal dismissing a $120 million Central Bank fine but continues to contest tax assessments.
- Competition Investigations: French and Swiss competition authorities have initiated inquiries into potential antitrust violations regarding information exchanges and distribution policies.
- Market Risks: The company faces exposure to foreign currency fluctuations (75% of sales are outside the U.S.), rising raw material costs (resins, tallow, corn), and increasing dependence on key retail customers.
Investor Verification Checklist
- Restructuring Progress: Verify the timeline and cost realization of the 2004 Restructuring Program, specifically the closure of manufacturing facilities in the U.S. and Europe.
- Brazilian Litigation: Monitor the status of the Brazilian tax assessments and criminal charges related to the Kolynos acquisition financing.
- Antitrust Compliance: Track the outcomes of the French and Swiss competition law investigations.
- Divestiture Completion: Confirm the closing of the Latin American bleach brand sale expected in the first half of 2007.
- Stock-Based Compensation: Assess the ongoing impact of SFAS 123R adoption on future earnings per share.